LIMITED OFFER
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code is needed.
The Serotonin System
History, Neuropharmacology, and Pathology
- 1st Edition - June 15, 2019
- Editors: Mark Tricklebank, Eileen Daly
- Language: English
- Paperback ISBN:9 7 8 - 0 - 1 2 - 8 1 3 3 2 3 - 1
- eBook ISBN:9 7 8 - 0 - 1 2 - 8 1 3 3 2 4 - 8
The Serotonin System: History, Neuropharmacology, and Pathology provides an up-to-date accounting on the physiology and pathophysiology of serotonin and the role it plays in behavi… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteThe Serotonin System: History, Neuropharmacology, and Pathology provides an up-to-date accounting on the physiology and pathophysiology of serotonin and the role it plays in behavioral functions. In addition, the book explores the potential roles of 5-HT1 in neurodevelopmental disorders and summarizes the history of the discovery and development of serotonergic drugs for the treatment of neuropsychiatric disorders. This concise, yet thorough, volume is the perfect introduction to this critical neurotransmitter. It is ideal for students and researchers new to the study of behavior, neuropsychiatry or neuropharmacology, but is also a great resource for established investigators who want a greater perspective on serotonin.
- Examines the role of serotonin in physiological functions and neuropsychiatric disorders
- Provides in-depth knowledge on all aspects of the serotonin system
- Explores serotonergic receptors as targets for both current and new therapeutic compounds
Researchers, advanced students, and postdocs in neuroscience, psychiatry, pharmacology, and related areas with interests in the physiology and pharmacology of the serotonergic system in the animal and human brain
1. The metabolism of indoleamines
2. Neurodevelopmental Roles and The Serotonin Hypothesis of Autism Spectrum Disorder
3. The role of serotonin receptors in the control of cardiovascular function
4. Serotonin Receptors Nomenclature
5. A perspective: from the serotonin hypothesis to cognitive neuropsychological approaches
6. Endocrine and genetic moderation of serotonin systems and the psychopathology of affective disorders
7. Serotonin and sexual behavior
8. Serotonin and cognitive flexibility
9. Serotonin and Aggression
10. Serotonin and Sleep
11. Serotonin and the Psychedelics
12. Serotonin and nociception: from nociceptive transduction at the periphery to pain modulation from the brain
13. Serotonin and Feeding Regulation
14. The outlook for the development of serotonergic drugs as therapeutic medications for psychiatric disorders
- No. of pages: 306
- Language: English
- Edition: 1
- Published: June 15, 2019
- Imprint: Academic Press
- Paperback ISBN: 9780128133231
- eBook ISBN: 9780128133248
MT
Mark Tricklebank
Dr. Mark David Tricklebank, BSc MSc PhD DSc FBphS, earned his PhD from the University of Manchester, and after completing postdoctoral training at the Institute of Neurology, he joined the pharmaceutical company Merrell Dow in Strasbourg, where he was instrumental in the identification of the functional relevance of the newly identified 5-HT1A recognition site. He then moved to Merck at Terlings Park, where he worked with Susan Iversen to identify the behavioral effects of the NMDA receptor antagonist MK-801 and showed them to be identical to those of phencyclidine and ketamine. After then serving as head of the Mental Health Unit at Sandoz Pharma in Basel, he was appointed director of In Vivo Pharmacology at the Lilly Research Centre, Windlesham, where he conceived and founded the Lilly Centre for Cognitive Neuroscience, one of the first industrial-academic partnerships in the United Kingdom. After a varied career of several decades in the pharmaceutical industry, he now serves as a Wellcome Trust Fellow in the Institute of Psychiatry, Psychology and Neuroscience at King’s College London, and has published more than 160 papers.
Affiliations and expertise
Wellcome Trust Research Fellow, Department of Neuroimaging Sciences, Institute of Psychiatry, Psychology and Neuroscience, Kings College, London, UKED
Eileen Daly
Dr Eileen Daly, PhD, is a Senior Lecturer in the Department of Forensic and Neurodevelopmental Sciences at King’s College London. When at the National Institute of Aging, National Institutes of Health, USA, she measured neurotransmitter metabolites in human CSF and rodent brain. Relocating to the Institute of Psychiatry in London, she completed her PhD in Developmental Neuroscience with a project using Acute Tryptophan Depletion to modulate serotonin in Autism Spectrum Disorder, then looking at the brain with fMRI. She continues to study the role of neurotransmitters in developmental disorders and is the author of more than 100 papers.
Affiliations and expertise
Lecturer, Department of Forensic and Neurodevelopment Sciences, Institute of Psychiatry, Psychology and Neuroscience, King’s College, London, UKRead The Serotonin System on ScienceDirect